2. Content
Local anaesthetic
Introduction
History
Drug classification
Mechanism of action of LA
Pharmacokinetic of LA
Recent advances
General anaesthetic
Introduction
Drug classification
Mechanism of action of GA
Pharmacokinetics of GA
Recent advances
References
4. Introduction
Local anaesthetics (LAs) are drugs which upon topical
application or local injection causes reversible loss of seneory
perception , especially of pain , in a restricted area of the body.
These drugs act by blocking the conduction of nerve impulses
along the axon.
The clinically useful local anaesthetics are weak bases with
amphiphillic property. General structure of local anaesthetic
consist three parts 1. Lipophilic aromatic residue, 2 . Ester or
amide linkage ,3. Hydrophilic secondary or tertiary amine group
8. Drug classification of local anaesthetics
according to their Structure
Ester linked local
anaesthetics
Cocaine
Procoaine
Chloroprocaine
Tetracaine
Benzocaine
Amide linked local anaesthetics
Lidocaine
Bupivacaine
Dibucaine
Prilocaine
Ropivacaine
9. Mechanism of action of local anaesthetics
The main site of local anaesthetics is the cell membrane
The local anaesthetics in unionised form easily penetrate nerve sheat and axon
membrane.
Within the axoplasm the molecule become ionised and block the voltage gated
Na+ channel .
1. Local anaesthetics are weak base . At tissue pH 7.4 ( alkaline pH ) they partly
unionised and partly ionised
2. The unionised drug penetrate inside the nerve membrane
3. Enter in axon ( axonal pH is low )
4. LAs blocks the voltage gated Na+ channel from inside
5. No entry of Na+ ions into the neuron
6. Depolarisation doesn’t occurs
7. No generation of action potential
8. No generation and conduction of impulses to CNS
9. Reversible loss of seneory perception without loss of consciousness( local
anaesthetic action )
10. Pharmacokinetics of LAs
Absorption
Systemic absorption of injected local anesthetic from the site of administration is
determined by several factors, including dosage, site of injection, drug-tissue binding,
local blood flow
Application of a local anesthetic to a highly vascular area such as the tracheal mucosa
or the tissue surrounding intercostal nerves results in more rapid absorption.
Distribution
The amide local anesthetics are widely distributed after intravenous bolus
administration.
After an initial rapid distribution phase, which consists of uptake into highly perfused
organs such as the brain, liver, kidney, and heart, a slower distribution phase occurs
with uptake into moderately well-perfused tissues, such as muscle and the
gastrointestinal tract.
11. Metabolism & Excretion
The local anesthetics are converted in the liver (amide type) or in plasma (ester
type) to more water-soluble metabolites and then excreted in the urine.
Ester type LA is metabolized by pseudocholinesterase and amide type by hepatic
microsomal enzymes and enzyme amidase.
Side effects of LAs
Cardiovascular -depression of heart, bradycardia, hypotension, cardiac
arrhythmias etc.
CNS-rapid absorption produce restlessness, tremor, convulsions.
Anaphylactic reaction-common with ester type.-causes asthma, dermatitis, skin
rash eetc
Corneal change-very rarely reversible corneal change may occur.
12. Cocaine
First local anaesthetic obtained from leaves of plant Erythroxylon Coca.
It is no more in use nowadays because of its corneal toxicity, addicting nature etc.
Procaine
First synthetic local anaesthetic . Used as a small area infiltration and spinal anaesthetic.
It is poorly absorbed from mucous membraneso no topical use.
2% injection is the usual preparation.
Lignocaine
Most commonly used LA
In ophthalmology 4% [topical] and 2% [infiltration] solutions are commonly used.
It has quick onset of action and high degree of penetration
The drug is recommended for topical, nerve block, infiltration and epidural injection and
for dental analgesia.
It may cause drowsiness.
13. Benzocaine
It is an ester of amino-benzoic acid that lacks a cationic
amino terminus which makes benzocaine poorly soluble
in water and a poor candidate for parentral use. It is
available in the forms of Spray, gel, gel-patch, ointment or
solution as 6-20% and in different flavours also.
Brand names available : Orajel, Hurricaine
Combinations of benzocaine :
1. Orabase- combination of benzocaine,gelatin, pectin &
sodium carboxymethylcellulose
2. Cetacine: It contains 14% benzocaine, 2% butamen, 2%
tetracaine Hcl
14. Commonly used drug with LA
Adrenaline –to prolong the effect of LA and to reduce
the toxicity by reducing absorption from local area.
Hyaluronidase-enzyme which cause depolymerization
of hyaluronic acid and increase the permeability of injected
fluid.
15. Recent advances in LAs
Newer LA agents
LA delivery system
1. Computer controlled local anaesthetic delivery system ( CCLAD)
2. Jet injection
3. Safety dental syringes
4. Devices for intraosseous LAs
Latest Trends :- Nasal spray, liposomal delivery system, syringe merovibrator ,
Dentipatch , TENS( Transcutaneous electrical nerve stimulator )
Future of LA :- Nanoanesthesia
16. 1.Newer LA Agents
Two relatively new drugs that have proved to be equally or more efficient to
lignocaine are :-
A. Articaine
B. Centbucridine
17. Articaine
It belongs to the amide group of local anaesthetics
It consists of a thiophene ring instead of a benzene ring as in an ester
group
Metabolism is mainly in the liver and plasma by unspecified plasma
esterases Elimination of articaine is exponential with a half life of about 20
min.
18. Articaine V/S Lignocaine
Articaine has a faster onset of action
Articaine has a longer duration of action
Articaine has higher success rate
Articaine has a greater potency ( 1.5 times more potent )
Systemic intoxication of articaine is lower
Articaine is a very safe drug
19. Centbucridine
It is anaesthetic molecule synthesized at the centre for Drug
Research of India at Lucknow , India in the year 1983
It is a quinolone derivative with local anaesthetic action
It has intrinsic vasoconstricting and anti histaminic properties
Centbucridine in a concentration of 0.5 % can be used
effectively for infiltration , nerve blocks and spinal
anaesthesia with an anesthetic potency 4-5 times greater
than that of 2% lignocaine
20. Hurripak
Hurripak which contains 20% benzocaine is anaesthetic
liquid which is one of the recent development topical
anaesthetics for periodontal procedures.
It is available as a needle –free periodontal anaesthetic
kit.
It consists of 3ml plastic syringe and disposable plastic
tips which are inserted deep within the gingival sulcus.
The onset of action is 30 seconds and the duration of
action is 15 minutes.
Sometimes it won’t provide adequate anaesthesia for a
routine dental visit on adult patients, so multiple
administration is recommended
21. Precooling (Cryo Anaesthesia)
It is the application of cold to a localised part of body in order to block the local
nerve conduction of painful impulses. The local application of ice before and
sometimes after painful procedures has been practiced for thousands of years and
was one of the first source of local anaesthesia and analgesia.Topical cold
application stimulates myelinated A fibers, activating inhibitory pain pathways
which in turn raises pain threshold. Iqra et al 2015 in her article concluded that,
cooling will slow down or eliminate transmission of pain signals. It is available in
ice (crushed ice or cubed ice), refrigerant spray forms The trade names of
refrigerant spray are Gebauer’s pain ease, Pharma ethyl
Advantages of precooling:
1. It produces immediate anaesthesia as it suppresses both pain and pressure
2. It is an easy, reliable, and effective technique.
3. It is comfortable, safe and physiologically active.
4. Cost effective.
22. Iontophoresis
Iontophoresis is a method of enhancing the transport of topically applied
drugs using a mild electric current to increase the permeability of charged
drugs through the skin.
Mechanism of action: The drug which can exists in positively charged state
like lignocaine and adrenaline can be encouraged to penetrate the tissue
under the influence of electrical charge. The apparatus consists of two
electrodes and a circuit. The electrode has to be placed over the tooth to
be treated and the other one is applied to the skin over the surface of the
wrist, with the help of iontophoretic apparatus and a low votage direct
current (0-3ma) is applied, which travels through the skin reaches
underlying connective tissue goes back the same path and is
collected by a return electrode. The ions of the drug traverse through the
same path as the current. This procedure will enhance the penetration of
the drug by 20–60-fold when compared with topical application
23. Advantages
1. Patient acceptance is very high.
2. Provide rapid and effective anaesthesia compared to topical anaesthesia alone.
Disadvantages
1. At higher current densities or upon longer application, it can cause skin irritation.
2. Sometimes mild electrical sensation can be uncomfortable for some patients.
3. Equipment is expensive and bulky
4. Cannot be used over large surface areas of the body.
24. Computer controlled local anaesthetic
delivery system (CCLAD)
In 1997 the first computer controlled local anaesthetic delivery system was
introduced into dentistry
25. Advantages
Disadvantages
Results in a controlled, highly effective and comfortable injection
even in resilient tissue
It’s very expensive
Required additional armamentarium
26. Jet Injection Based on the principle of using a
mechanical energy source to
create a release of pressure
sufficient to push a dose of liquid
medication through a very small
orifice, creating a thin column of
fluid with enough force that it can
penetrate soft tissue into the
subcutaneous tissue without a
needle .
28. TENS ( Transcutaneous electrical nerve
stimulator )
It is non invasive , safe and
can be used to achieve
anesthesia in needle-phobic
patients.
Patient are able to self
administer TENS treatment
and learn to titrate dosages
accordingly to manage their
painful condition. This results
in positive acceptance by
the patients .
29. Nanoanesthesia
Nanotechnology uses millions of active
analgesic micrometer sized dental
nanorobots in a colloidal suspension for
local anesthesia.
On reaching the dentin , the nanorobots,
within 100 sec , are said to enter dentinal
tubular holes that are 1-4um in diameter
and proceed toward the pulp , guided by a
combination of chemical gradients ,
temperature differential and even position
of navigation , all under the control of the
onboard nanoconputer as directed by
dentist.
31. Introduction
General anesthesia is a reversible state of CNS depression, causing loss of
response to and perception of stimuli. For patients undergoing surgical
or medical procedures,
Anesthesia provides five important benefits:
Sedation and reduced anxiety
Lack of awareness and amnesia
Skeletal muscle relaxation
Suppression of undesirable reflexes
Analgesia
Because no single agent provides all desirable properties both rapidly
and safely, several categories of drugs are combined (I.V
and inhaled anesthesia and preanesthetic medications) to
produce optimal anesthesia known as a Balanced anesthesia.6
33. Mechanism of action of GAs
No specific receptor has been identified. The fact that chemically unrelated
compounds produce anesthesia argues against the existence of a single receptor.
The focus is NOW on proteins comprising ion channels:
GABAA receptors, Glycine receptors,
NMDA glutamate receptors (nitrous oxide and ketamine )
Nicotinic receptors: Blocks the excitatory postsynaptic current of the nicotinic
receptors.
Currently, there are 5inhalational and 5 intravenous anesthetics used to induce or
maintain
general anesthesia: Inhalational:Nitrous Oxide, Isoflurane, Sevoflurane,
etomidate and Xenon.
Intravenous: Propofol, Etomidate, Ketamine, Methohexita
and Thiopental.
These 10 general anesthetic drugs are often accompanied by sedative
benzodiazepines: midazolam, diazepam and lorazepam.
34. Continue…
Of these 10 general anesthetics ketamine , nitrous oxide and xenon
inhibit ionotropic glutamate receptors, with the strongest effects being
seen on the NMDA receptor subtype. These anesthetics also have
modest effects on many other receptors, including GABAARs, but their
primary action is the blockade of NMDA receptors.
The other 7 general anesthetics and 3 sedatives share a common target
and mechanism of action, they all enhance the function of GABAARs, the
most abundant fast inhibitory neurotransmitter receptor in the CNS.
These 7 general anesthetics also have a spectrum of modest to strong
effects on other ion channels, including glycine receptors, neuronal
nicotinic receptors, 5-HT3 receptors, glutamate receptors and the
potassiu channels.Mechanisms underlying the anesthetic effect are not
properly known yet.
35. Minimum alveolar concentration (MAC)
It is the Minimum alveolar concentration, the
endtidal Concentration Of inhaled anesthetic
Needed to eliminat Movemen in 50 % of
Patients stimulated by a standardized incisi.
MAC is the ED50 of the anesthetic.
the inverse of MAC is an index of potency of
the anesthetic.
MAC expressed as the percentage of gas in a
mixture required to achieve the effect.
Numerically, MAC is small for potent
anesthetics such as sevoflurane and large for
less potent agents such as nitrous oxide.
36. Pre anesthetic medication
Preanesthetic medications serve to
calm the patient, relieve pain
protect against undesirable effects of the subsequentlyadministered anesthetics or the surgical
procedure.
facilitate smooth induction of anesthesia, lowered the required dose of anesthetic
Preanesthetic Medicine:
Benzodiazepines; midazolam or diazepam: - Anxiolysis & amnesia.
Diphenhydramine:- Prevention of allergic reactions: - antihistamines
H2 receptor blocker- famotidine, ranitidine: Reduce gastric acidity.
Antiemetics- ondansetron: Prevents aspiration of stomach contents and post surgical vomiting
Acetaminophen or opioids (fentanyl) for analgesia
Anticholinergics: (glycopyrrolate, scopolamine):
Reduce bronchial and salivary secretion: irritant inhaled anesthetic cause excessive salivation and
secretion.
37. Stages of GAs
Stage I :- Analgesia
analgesia and amnesia, the patient is conscious and
conversational. Starts from beginning of anaesthetic inhalation
and lasts upto the loss of consciousness
Pain is progressively abolished
Reflexes and respiration remain normal
Use is limited to short procedures
38. Stage II :- Delirium
From loss of consciousness to beginning of regular
respiration
Patient may shout, struggle and hold his breath; muscle tone
increases, jaws are tightly closed, breathing is jerky; vomiting,
involuntary micturition or defecation may occur
Heart rate and BP may rise and pupils dilate due to
sympathetic stimulation
No operative procedure carried out
Can be cut short by rapid induction, premedication
39. Stage III:- Surgical Anasthesia
Extends from onset of regular respiration to cessation of
spontaneous breathing. This has been divided into 4 planes
which may be distinguished as:
Plane 1 moving eye balls. This plane ends when eyes
become fixed.
Plane 2 loss of corneal and laryngeal reflexes.
Plane 3 pupil starts dilating and light reflex is lost.
Plane 4 Intercostal paralysis, shallow abdominal respiration,
dilated pupil.
40. Stage IV :- Medullary paralysis
Cessation of breathing – failure of circulation – death
Pupils: widely dilated
Muscles are totally flabby
Pulse is imperceptible
BP is very low.
41. 1. Diethyl ether (C2H5 – O – C2H5)
Colourless, highly volatile liquid with a pungent odour. Boiling point – 35ºC
Produces irritating vapours and are inflammable and explosive
Pharmacokinetics:- 85 to 90 percent is eliminated through lung and remainder
through skin, urine, milk and sweat- Can cross the placental barrier
Advantages-
1. Can be used without complicated apparatus
2. Potent anaesthetic and good analgesic
3. Muscle relaxatio
4. Wide safety of margin
5. Respiratory stimulation and bronchodilatation
6. Does not sensitize the heart to adrenaline- No cardiac arrythmias
7. Less likely hepato or nephrotoxicity
Disadvantages- Inflammable and explosive- Slow induction and unpleasant –
atrethy- Slow recovery – nausea & vomitin- Cardiac arres- Convulsion in children -
Cross tolerance – ethyl alcohol
42. 2. Nitrous oxide/laughing gas (N2O)
Colourless, odourless inorganic gas with sweet taste
Noninflammable and nonirritating, but of low potency
Very potent analgesic
As a single agent used with O2 in dental extraction and in obstetrics
3. Halothane
Fluorinated volatile liquid with sweet odour, non-irritant non-inflammable and
supplied in amber coloured bottle
Potent anaesthetic, 2-4% for induction and 0.5-1% for maintenance
Pharmacokinetics: 60 to 80% eliminated unchanged. 20% retained in body for 24
hour and metabolized
43. Recent advances in GAs
New inhalational anaesthetics allow rapid, pleasant gaseous induction of
anaesthesia and rapid recovery with a minimal “hangover” effect
Target controlled infusion techniques have improved the accuracy of total
intravenous anaesthesia and pave the way for “closed loop” automatic
anaesthesia
A unique opioid, remifentanil, allows fine control of intraoperative
analgesia but its effects wear off within minutes of stopping infusion
Separation of stereoisomers has allowed the development of improved
safer local anaesthetics
Mobile epidurals are rapidly gaining popularity in labour wards because
they allow normal mobility with high quality pain relief
Neurokinin type 1 receptor antagonists promise to further improve
management of postoperative nausea and vomiting
Recent developments in equipment have helped to minimise the
problems of anaesthetising patients with “difficult” airways
44. Bisprctral Index
The newer technologies
include the bisprctral
Index (BIS)which purport
to monitor the depth of
anesthetic agents to a
specific bisprctral index
during general
anaesthesia allows the
anaesthetist to adjust
the amount of
anaesthetic agents to
needs of the patient.
45. Target controlled infusion
Target controlled infusion systems allow the anaesthetist to set a desired plasma concentration,
which the software inside the pump produces rapidly but safely by controlling the infusion rate
according to complex but standard pharmacokinetic equations.
12,13 Changes may still be required according to clinical signs, but the technique enables
changes in rate to reflect factors such as patient characteristics, previous administration of
propofol, and duration of infusion
If a reliable monitor of anaesthetic depth becomes available it will be possible to “close the loop”
and provide virtually automatic anaesthesia by feedback control of a target controlled infusion
system.
Much research has focused on this, with the aim of producing a machine that will reliably indicate
whether a paralysed patient is anaesthetised.
Unfortunately, autonomic clinical signs do not always detect an aware patient especially in the
presence of drugs that affect these signs, such as β blockers.
Recent work has concentrated on measurements derived from an electroencephalogram, but
most of these are unreliable or too complex for practical use.
The auditory evoked potential index—a single numerical variable derived from the auditory
evoked potential—was found to show consistent changes that may reliably detect awareness.
15,16 Prototype closed loop systems, using the auditory evoked potential index to control
propofol given by target controlled infusion, have been described.
46. Remifentanil
Remifentanil is a new potent synthetic opioid ideally suited for infusion
(often with a target controlled infusion system) during anaesthesia.
Unlike other opioids, remifentanil contains a methyl ester in its structure,
which allows rapid extrahepatic non-saturable metabolism by non-
specific esterases in blood and tissues.
The terminal half life of remifentanil is less than 10 minutes and, unlike all
other opioids, this is not affected by duration of iinfusion.
Remifentanil’s place in anaesthesia has yet to be fully determined. Critics
point out the lack of postoperative analgesia with remifentanil, but it is
already widely used during neuroanaesthesia and is likely to represent a
significant advance in several other areas such as cardiac and
cardiovascular anaesthesia.
47. References
Essential of medical pharmacology – K.D. Tripathi 7th edition
Lippincott – Modern Pharmacology With Clinical Applications 6E
International Journal of Advanced Research ( IJAR) -Dr.Hridya M. Menon , Dr.
Shilpa Jaidka , Dr. Rani Soman